Title for MeetingAbstracts
Alphabetical listing of titles
-
Antifungal Activity of Isomeric Forms of Nystatin (NYS).
-
Antifungal activity of LY303366 (LY), an echinocandins beta glucan synthase inhibitor (GSI).
-
Antifungal activity of MDI-P against Candida albicans (C.a.).
-
ANTIFUNGAL ACTIVITY OF NUCLEOSIDE ANALOGUES AND NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS.
-
Antifungal activity of polyhexamethylene biguanide solution versus agents of fungal keratitis.
-
Antifungal Activity of Posaconazole, Ravuconazole, and Voriconazole Compared to That of Itraconazole Tested Against 213 Clinical Isolates of Aspergillus spp. and Other Filamentous Fungi: Report from the SENTRY Antimicrobial Surveillance Program, 2000.
-
Antifungal Activity of Sordarin Derivatives against Fluconazole-Susceptible and -Resistant Candida albicans.
-
Antifungal Activity of Sordarin Derivatives against Nonlethal Models of Candidiasis in Rats.
-
Antifungal activity of the new semisynthetic echinocandin B derivative LY 303366 against pathogenic yeasts and Aspergillus spp.: a comparative study.
-
Antifungal activity of the new triazole voriconazole against established, new and emerging yeast pathogens: a comparative study.
-
Antifungal activity of voriconazole against fungemic Candida species and Cryptococcus neoformans isolated from blood cultures of neutropenic patients in a Canadian tertiary care hospital from 1986-1997.
-
Antifungal Activity, Plasma Pharmacokinetics and Safety of Caspofungin in Experimental Pulmonary Aspergillosis in Persistently Neutropenic Rabbits.
-
Antifungal Agents and Biofilm.
-
Antifungal and biocide susceptibility testing of Candida biofilms, using the MBEC(TM) device.
-
Antifungal Chemotherapy: From Amphotericin B to the Future.
-
Antifungal Compounds from Endophytic Fungi.
-
Antifungal cross-resistance among Candida spp. recovered from fluconazole-refractory thrush in AIDS patients.
-
Antifungal Drug Response in an In Vitro Model of Dermatophyte Nail Infection.
-
Antifungal Drug Susceptibility of Candida spp. Bloodstream Isolates: A U.S. Population-Based Study.
-
Antifungal Drugs, Sterol Biosynthesis, and an Ancestral Cytochrome P450 Target.
-
Antifungal effect of fluconazole (Flu), azithromycin (AZ) or their combination on intracellular Candida albicans (C.a.).
-
Antifungal effect of glycyrrhizin (GR) on Candida albicans infection in thermally injured mice.
-
Antifungal Effect of Voriconazole on Intracellular Candida glabrata, Candida krusei, and Candida parapsilosis in Human Monocytes.
-
Antifungal effects of lanoconazole on Cryptococcus neoformans infection in MAIDS mice.
-
Antifungal efficacy of recombinant human Chitinase in murine candidiasis and aspergillosis.
-
Antifungal interventions for the primary prevention of cryptococcal disease in persons with HIV: a systematic review.
-
Antifungal pharmacodynamic activity of the investigational echinocandin LY303366 against fluconazole-sensitive (FLU-S) and fluconazole-resistant (FLU-R) Candida albicans.
-
Antifungal properties of the natural peptides Cecropin B and Dermaseptin.
-
Antifungal Prophylaxis and Treatment: Pitfalls and Trade Offs.
-
Antifungal Prophylaxis beyond Bone Marrow Transplantation and Acute Leukemia.